EP3952837A1 - Ointment for the treatment of burns - Google Patents
Ointment for the treatment of burnsInfo
- Publication number
- EP3952837A1 EP3952837A1 EP20718759.2A EP20718759A EP3952837A1 EP 3952837 A1 EP3952837 A1 EP 3952837A1 EP 20718759 A EP20718759 A EP 20718759A EP 3952837 A1 EP3952837 A1 EP 3952837A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- olive oil
- burns
- oil
- treatment
- ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 18
- 230000035876 healing Effects 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 16
- 241000272814 Anser sp. Species 0.000 claims abstract description 11
- 239000004006 olive oil Substances 0.000 claims abstract description 11
- 235000008390 olive oil Nutrition 0.000 claims abstract description 11
- 229940124530 sulfonamide Drugs 0.000 claims abstract description 10
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 239000004615 ingredient Substances 0.000 claims abstract description 6
- 235000019484 Rapeseed oil Nutrition 0.000 claims abstract description 5
- 235000019271 petrolatum Nutrition 0.000 claims abstract description 5
- 239000011719 vitamin A Substances 0.000 claims abstract description 5
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 5
- 206010040882 skin lesion Diseases 0.000 claims abstract description 4
- 231100000444 skin lesion Toxicity 0.000 claims abstract description 4
- 230000009286 beneficial effect Effects 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 11
- 235000019197 fats Nutrition 0.000 claims description 8
- 239000010463 virgin olive oil Substances 0.000 claims description 6
- 238000010297 mechanical methods and process Methods 0.000 claims description 5
- 230000005226 mechanical processes and functions Effects 0.000 claims description 5
- 230000003902 lesion Effects 0.000 claims description 4
- 239000010462 extra virgin olive oil Substances 0.000 claims description 3
- 235000021010 extra-virgin olive oil Nutrition 0.000 claims description 3
- 238000001033 granulometry Methods 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 239000000470 constituent Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 2
- 244000048738 European olive Species 0.000 claims 1
- 235000019482 Palm oil Nutrition 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000002925 chemical effect Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000004040 coloring Methods 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 230000005611 electricity Effects 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 239000003346 palm kernel oil Substances 0.000 claims 1
- 235000019865 palm kernel oil Nutrition 0.000 claims 1
- 239000002540 palm oil Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000001991 pathophysiological effect Effects 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 1
- 235000019871 vegetable fat Nutrition 0.000 claims 1
- 239000008158 vegetable oil Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 9
- 231100000241 scar Toxicity 0.000 abstract description 7
- 239000000843 powder Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 208000032544 Cicatrix Diseases 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract description 2
- 230000037387 scars Effects 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000003179 granulation Effects 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 239000004744 fabric Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 3
- 230000037390 scarring Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010006797 Burns first degree Diseases 0.000 description 1
- 206010006802 Burns second degree Diseases 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Definitions
- the invention relates to an ointment for the treatment of burns and is the product of intense mixing and mild heat treatment of the following ingredients: olive oil, petroleum jelly, goose fat, sulfanilamide powder, rapeseed oil, vitamins A, D and E.
- This ointment has the advantage of other products which are not therapeutic but preservative.
- This treatment can mainly heal damaged skin tissues from burns of the first (1st), second (2nd) but also equally and third (3rd) degree and as well as wounds that come from the lesions.
- the estimated third-degree burn healing beginning is from ten (10) to twenty-one (21) days, with the most common beginning of healing at fourteen (14) days.
- the use of this ointment reduces healing in half the time compared to other methods and products, but its main feature is that it leaves no scars after healing.
- the precondition for this to happen, however, is its application from the first day of the burn, as well as how it is applied: a sufficient amount of ointment is applied to a cotton cloth wich is sterile, applied in order to heal to the wound so that no grid (scar tissue) appears on the wound during healing. This also helps protect the wound against exogenous contaminants. Change to this fabric is done every 48 hours, and the sterile fabric is glued to the healthy areas of the skin with paper tape the other way so as to breath the skin.
- Exemplary other similar techniques are based on patents such as RU2452475C2, CN102349920B, US3761590, which generally refer to the use of sulfanilamide and other active compounds that belong to the group of sulfonamides, such as having sulfadiazine that are antibacterial and antibiotic action, but not in powder form with specific grains, nor in combination with the use of olive oil, petroleum jelly, goose fat, rapeseed oil and vitamins A, D and E.
- This preparation is in the form of an ointment, resulting from intense mixing and gentle heating, for a period of twenty (20) to thirty (30) minutes, and then stored in a shady and cool place at a temperature of four (4° C) to twenty-five (25 ° C) degrees Celsius and the exact method of preparation is as follows:
- the mixing of the ingredients takes place in a double-walled container and. at a constant temperature for a period of twenty (20) to thirty (30) first minutes of the hour with a constant mixing rate.
- a vacuum and pressure mixer or homogenizer mixer or pressure cooker assemblies are designed to provide high quality productions of pharmaceutical preparations and cosmetics, gels, toothpaste, mascara, hair care products etc.
- the mixing temperature should remain constant throughout the mixing as deviations adversely affect the result and the optimum temperature range is from twenty (20° C) to forty (40° C) degrees Celsius, preferably from twenty-five (25° C) to thirty-five (35° C) degrees Celsius, ideally from twenty-seven (27° C) to thirty-two (32° C) degrees Celsius.
- the rotational speed during homogenization may be from 2800 rpm to 3100 rpm, preferably from 2850 rpm to 3050 rpm, ideally from 2900 rpm to 3000 rpm.
- the mixing sequence is as follows: first mix the first (1st) with the second (2nd) and then add the third (3rd) to the resulting mixture and then add the fifth (5th) to the resulting mixture component and then to the resulting mixture is added the fourth component (4th).
- goose fat should be golden in color without any foreign matter and be homogeneous, with a characteristic odor of goose.
- the goose fat treatment should be mild and have a maximum treatment temperature of eighty (80° C) degrees Celsius.
- Sulfanilamide should be fine-grained, if it does not have the necessary granulometry characteristics, the friction component is converted to a finer powder, in particular less than thirty (30mm) microns, preferably less than twenty two (22mm), ideally the granulometry should be from sixteen microns (16mm) to twenty two microns (22mm) .
- Olive oil is preferably 2-3% low-acid olive oil and even better Virgin Olive Oil, which is virgin olive oil, that is olive oil produced only by natural and mechanical processes, with good organoleptic characteristics, with a free acidity of not more than 2.0%, and even better Extra Virgin Olive Oil, which is virgin olive oil, produced solely by natural and mechanical processes, with a perfect aroma and taste, with a free acidity of not more than 0.8%.
- the final moisture content of the ointment should be from 10% to 20% by weight, preferably from 12.5% to 17.5% by weight.
- the above product after being stored in the refrigerator, takes the form of a pale yellow aqueous ointment with a characteristic odor of goose and butter.
- the above product after its airtight packaging, remains active, in a refrigerator of four (4° C) degrees Celsius and at a temperature of up to twenty-five (25° C) degrees Celsius, in a shady and cool place for twelve (12) months.
- the preservative used is potassium sorbate from 0.1% to 0.3% by weight, preferably from 0.1% to 0.2% by weight.
- the ointment is suitable for burns of all three degrees, as defined below based on the depth of the injury. In addition, it is also suitable for healing of other skin lesions such as openings in the skin caused by bedtime.
- the ointment is suitable for:
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20190100123A GR1009789B (en) | 2019-03-18 | 2019-03-18 | Ointment for burns |
PCT/GR2020/000017 WO2020188305A1 (en) | 2019-03-18 | 2020-03-13 | Ointment for the treatment of burns |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3952837A1 true EP3952837A1 (en) | 2022-02-16 |
Family
ID=70285723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20718759.2A Pending EP3952837A1 (en) | 2019-03-18 | 2020-03-13 | Ointment for the treatment of burns |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3952837A1 (en) |
GR (1) | GR1009789B (en) |
WO (1) | WO2020188305A1 (en) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1525285A (en) * | 1922-04-24 | 1925-02-03 | Gabbola Raffaele | Composition for use as a salve or ointment |
US3761590A (en) | 1970-05-18 | 1973-09-25 | Research Corp | Silver sulfadiazine used in the treatment of burns |
US7357923B1 (en) * | 1995-10-30 | 2008-04-15 | Cac Pharmaceuticals | Topical medicament for skin injuries and disorders |
GR1004321B (en) * | 2002-10-02 | 2003-08-28 | Μιραντα Βασιλειου Μιχαλακοπουλου | Ointment for healing burns |
RU2337702C2 (en) * | 2006-12-28 | 2008-11-10 | Лидия Ибрагимовна Гайсанова | Balsam "gaysanovoy", possessing wound healing, antiinflammatory and anti-burn activity |
CN101642575A (en) * | 2009-09-25 | 2010-02-10 | 惠连旺 | Ointment shape medicinal substrate |
RU2452475C2 (en) | 2010-06-17 | 2012-06-10 | Закрытое акционерное общество "СНС-фарма" | Agent for wounds, burns and infectious inflammatory diseases of skin, appendages and mucous membranes |
UA97076C2 (en) * | 2011-04-22 | 2011-12-26 | Светлана Владимировна Бабий | Anti-inflammatory ointment based on sulfanilamide |
CN102349920B (en) | 2011-08-10 | 2013-11-13 | 成都第一药物研究所有限公司 | Sulfanilamide medicament composition for wound surface |
US11813284B2 (en) * | 2013-08-08 | 2023-11-14 | Novan, Inc. | Topical compositions and methods of using the same |
CN107929098A (en) * | 2017-12-06 | 2018-04-20 | 杨益文 | A kind of cosmetics and skincare product and the pharmaceutical composition for treating burn and scald |
WO2019125313A1 (en) * | 2017-12-21 | 2019-06-27 | Caliskan Muharrem | Burn treatment cream and production method thereof |
-
2019
- 2019-03-18 GR GR20190100123A patent/GR1009789B/en active IP Right Grant
-
2020
- 2020-03-13 WO PCT/GR2020/000017 patent/WO2020188305A1/en unknown
- 2020-03-13 EP EP20718759.2A patent/EP3952837A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GR1009789B (en) | 2020-08-03 |
WO2020188305A1 (en) | 2020-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9283173B2 (en) | Emulsified wax compositions and uses thereof | |
JP6778219B2 (en) | Igai adhesive protein products that suppress skin inflammation and their applications | |
US20230338435A1 (en) | Topical composition comprised of cod li ver oil for treating wounds and skin disorders | |
CN109219442A (en) | Fish oil topical composition | |
KR20130055182A (en) | Composition for improving acnes and kit for improving acnes containing the same | |
US6780444B1 (en) | Method of making cosmetic, pharmaceutical, and dermatological compositions and compositions made according to the method | |
WO2020188305A1 (en) | Ointment for the treatment of burns | |
KR20160041302A (en) | Manufacturing method of cosmetic for acned skin containing hydrozol | |
RU2543355C1 (en) | Dry face mask | |
KR102218008B1 (en) | Manufacturing method of hydrogel mask pack by using aloe and hydrogel mask pack by the same | |
KR102215331B1 (en) | Laser treatment for pain relief How to make cosmetics For pain application | |
KR101967576B1 (en) | Anti-Atopy, Anti-microbial and Anti-inflammatory Cosmetic Composition Containing a White Rose Extract Stabilized with Lamella Liposome | |
RU2369377C1 (en) | Phytobalsam insofit for skin regeneration | |
US20200188351A1 (en) | Topical hair and skin formulation | |
RU2186561C2 (en) | Cream for dry and normal face skin | |
KR100289906B1 (en) | Dermatological composition | |
RU2182820C1 (en) | Stimulating cosmetic cream | |
KR100592429B1 (en) | Burn treatment comprising bamboo epidermal powder and its preparation method | |
KR102013406B1 (en) | Composition for preventing hair loss and promoting hair growth | |
RU2157176C1 (en) | Curative balsam | |
BE677435A (en) | ||
HU228081B1 (en) | Emulsion composition comprising elder-berry extract and alum and using for cosmetic treatment vein | |
Chatur et al. | Research Article Formulation and Evaluation of Panchamrut Polyherbal Scrub. | |
FR2857261A1 (en) | Cosmetic or pharmaceutical product, useful e.g. as a mask, comprising absorbant support impregnated with a composition containing active care agent | |
KR20040024160A (en) | Germanium -containing cosmetic composition, and face pack produced therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20211222 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240220 |